Art. 6 Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…

Data requirements for an application

In forcecited 12×
1.

An application for approval of an active substance shall contain at least the following elements:

(a)

a dossier for the active substance satisfying the requirements set out in Annex II;

(b)

a dossier satisfying the requirements set out in Annex III for at least one representative biocidal product that contains the active substance; and

(c)

if the active substance meets at least one of the exclusion criteria listed in Article 5(1), evidence that Article 5(2) is applicable.

2.

Notwithstanding paragraph 1, the applicant need not provide data as part of the dossiers required under points (a) and (b) of paragraph 1 where any of the following applies:

(a)

the data are not necessary owing to the exposure associated with the proposed uses;

(b)

it is not scientifically necessary to supply the data; or

(c)

it is not technically possible to generate the data.

However, sufficient data shall be provided in order to make it possible to determine whether an active substance meets the criteria referred to in Article 5(1) or Article 10(1), if required by the evaluating competent authority under Article 8(2).

3.

An applicant may propose to adapt the data as part of the dossiers required under points (a) and (b) of paragraph 1 in accordance with Annex IV. The justification for the proposed adaptations to the data requirements shall be clearly stated in the application with a reference to the specific rules in Annex IV.

4.

The Commission shall be empowered to adopt delegated acts in accordance with Article 83 specifying criteria for determining what constitutes adequate justification to adapt the data requirements under paragraph 1 of this Article on the grounds referred to in point (a) of paragraph 2 of this Article.

The 10 that are cited most themselves, of 12.

  • Commission Implementing Regulation (EU) No 88/2014 of 31 January 2014 specifying a proce…4Law

    … на допълнителни данни съгласно параграф 2 изцяло съответства на член 6 от Регламент (ЕС) № 528/2012, по искане на заявителя а) се …

  • The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Am…217Law

    … or inclusion in category 6 of the Simplified Active Substance List containing the data required in accordance with Article 6(1) and (2) of Regulation (EU) No 528/2012 has been accepted by the competent authority and the appropriate fee has …

  • Judgment of the General Court (Seventh Chamber) of 15 September 2021. Laboratoire Pareva and Biotech3D Ltd & Co. KG v European Commission.Decision

    First of all, it is true that, in the December 2016 assessment report, in its part common to product-types 1, 2, 4, 5 and 6, the evaluating competent authority found the existence of a harmonised classification of PHMB in Annex I to …

    15 Sep 2021 · 62018TJ0337

  • Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme…5Law

    … or inclusion in category B of the Simplified Active Substance List containing the data required in accordance with Article 6(1) and (2) of Regulation (EU) No 528/2012 has been accepted by the competent authority and the appropriate fee has …

  • Opinion of Advocate General Rantos delivered on 20 May 2021. Biofa AG v Sikma D. Vertriebs GmbH und Co. KG.Decision

    The applicant for approval of a substance is to submit its application for approval to the ECHA, to which it communicates, in addition to the requisite data, [Article 6 of Regulation No 528/2012.] the name of the competent authority of the …

    20 May 2021 · 62020CC0029

  • Judgment of the Court (First Chamber) of 14 October 2021. Biofa AG v Sikma D. Vertriebs GmbH und Co. KG.Decision

    In addition, Article 6(1)(a) and (b) of that regulation provides that the application for approval of an active substance must include not only ‘a dossier for the active substance’ itself, but also ‘a dossier satisfying the …

    14 Oct 2021 · 62020CJ0029

  • Judgment of the Court (Eighth Chamber) of 10 November 2022. Laboratoire Pareva v European Commission.Decision

    On 31 July 2007, Laboratoire Pareva submitted a dossier, within the meaning of Article 6 of Regulation No 528/2012, relating to the application for approval of Pareva’s PHMB for product-types 1 (human hygiene), 2 (disinfectants and …

    10 Nov 2022 · 62021CJ0702

  • Decision_act (EU) 2018/1251Law

    По-специално по силата на член 6, параграф 2 от Регламент (ЕС) № 528/2012 заявителят трябва да предостави достътъчно данни, които да …

  • Decision_act (EU) 2024/2402Law

    Съгласно член 8, параграф 2 и член 6, параграф 2, втора алинея от Регламент (ЕС) № 528/2012 оценяващият компетентен орган поиска от …

  • Judgment of the General Court (Seventh Chamber) of 16 November 2022 (Extracts). Sciessent LLC v European Commission.Decision

    Moreover, Article 6 of Regulation No 528/2012 provides that, when applying for approval of an active substance, the applicant must provide the evaluating competent authority with a complete dossier for the active substance satisfying the …

    16 Nov 2022 · 62020TJ0122